suberoyl bis-hydroxamic acid has been researched along with Arthritis, Rheumatoid in 1 studies
suberoyl bis-hydroxamic acid: antineoplastic, Histone Deacetylase inhibitor
Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Grabiec, AM | 1 |
| Krausz, S | 1 |
| de Jager, W | 1 |
| Burakowski, T | 1 |
| Groot, D | 1 |
| Sanders, ME | 1 |
| Prakken, BJ | 1 |
| Maslinski, W | 1 |
| Eldering, E | 1 |
| Tak, PP | 1 |
| Reedquist, KA | 1 |
1 other study available for suberoyl bis-hydroxamic acid and Arthritis, Rheumatoid
| Article | Year |
|---|---|
Histone deacetylase inhibitors suppress inflammatory activation of rheumatoid arthritis patient synovial macrophages and tissue.
Topics: Adult; Aged; Apoptosis; Arthritis, Rheumatoid; Blotting, Western; Cells, Cultured; Female; Flow Cyto | 2010 |